| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/02/1999 | WO1999043712A1 Method for producing a factor viii/von willebrand factor complex |
| 09/02/1999 | WO1999043711A1 G protein-coupled receptor antagonists |
| 09/02/1999 | WO1999043710A1 Prostate-specific membrane antigens and methods of making and using |
| 09/02/1999 | WO1999043709A2 Melanocortin receptor antagonists and modulations of melanocortin receptor activity |
| 09/02/1999 | WO1999043708A1 Glp-1 derivatives of glp-1 and exendin with protracted profile of action |
| 09/02/1999 | WO1999043707A1 N-terminally modified glp-1 derivatives |
| 09/02/1999 | WO1999043706A1 Derivatives of glp-1 analogs |
| 09/02/1999 | WO1999043705A1 N-terminally truncated glp-1 derivatives |
| 09/02/1999 | WO1999043701A2 Peptides for inhibition of apoptosis and pharmaceutical compositions containing them |
| 09/02/1999 | WO1999043700A1 Calcium salts of lipopeptide antibiotics, method for producing same and their use |
| 09/02/1999 | WO1999043699A1 Streptogramin derivatives, preparation method and compositions containing same |
| 09/02/1999 | WO1999043697A1 Manganese superoxide dismutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms |
| 09/02/1999 | WO1999043693A1 36 human secreted proteins |
| 09/02/1999 | WO1999043692A1 pyrH GENE AND PROTEIN OF STREPTOCOCCUS PNEUMONIAE |
| 09/02/1999 | WO1999043361A1 Glp-2 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates |
| 09/02/1999 | WO1999043360A1 Stable protection from dystrophic sarcolemmal degeneration and restoration of the sarcoglycan complex |
| 09/02/1999 | WO1999043357A1 Indolicidin and cationic peptides conjugated with polymers |
| 09/02/1999 | WO1999043353A2 Combination anti-selectin and immunosuppressant therapy |
| 09/02/1999 | WO1999043352A1 Preventives/remedies for skin aging |
| 09/02/1999 | WO1999043347A1 Remedies for corneal epithelium disturbance |
| 09/02/1999 | WO1999043346A1 Methods for diagnosing and treating autoimmune disease |
| 09/02/1999 | WO1999043345A1 Amino acid degrading enzymes modulate cell death |
| 09/02/1999 | WO1999043344A2 Matrix protein compositions for wound healing |
| 09/02/1999 | WO1999043343A1 Novel peptide copolymer compositions |
| 09/02/1999 | WO1999043342A1 Somatotropin compositions mixed with vitamins |
| 09/02/1999 | WO1999043341A1 Glp-1 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates |
| 09/02/1999 | WO1999043340A1 Oral compositions at low dosage of cytotoxic proteins |
| 09/02/1999 | WO1999043339A1 A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof |
| 09/02/1999 | WO1999043338A1 Antibacterial drugs, methods for their design and methods for their use |
| 09/02/1999 | WO1999043337A1 Cyclic peptide antifungal agents |
| 09/02/1999 | WO1999043328A1 Treatment of hiv infections |
| 09/02/1999 | WO1999043308A2 Treating pulmonary hypertension through tenascin suppression and elastase inhibition |
| 09/02/1999 | WO1999043286A2 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 09/02/1999 | WO1999043271A1 Injectable implants for tissue augmentation and restoration |
| 09/02/1999 | WO1999043208A1 The helios gene |
| 09/02/1999 | WO1999033958A3 Desaturase |
| 09/02/1999 | WO1999033488A3 Adjuvanted vaccine formulation |
| 09/02/1999 | WO1999031240A3 14-3-3σ ARRESTS THE CELL CYCLE |
| 09/02/1999 | WO1999029814A3 Method of preparing lipoproteins, lipoaminoacids, lipid esters, and glucolipids from olive oil and/or its constituents which are condensed with vegetal protein hydrolysates or aminoacids or esterificated with fatty alcohols or sugars |
| 09/02/1999 | WO1999027109A3 EXTRACELLULAR MATRIX-BINDING PROTEINS FROM $i(STAPHYLOCOCCUS AUREUS) |
| 09/02/1999 | WO1999025732A3 Design of coiled-coil dimer derived antagonists of 4-helix bundle cytokine specific receptors |
| 09/02/1999 | WO1999024460A3 Dipeptide nitriles |
| 09/02/1999 | WO1999024075A3 Affinity markers for human serum albumin |
| 09/02/1999 | WO1999023209A3 ErbB-4 TARGETED RIBOZYMES |
| 09/02/1999 | WO1999023105A9 Vegi, an inhibitor of angiogenesis and tumor growth |
| 09/02/1999 | WO1999022772A9 LIPOSOMAL OLIGONUCLEOTIDE COMPOSITIONS FOR MODULATING ras GENE EXPRESSION |
| 09/02/1999 | WO1999019357A9 Cell regulatory genes, encoded products, and uses related thereto |
| 09/02/1999 | WO1999015548B1 Isolated and recombinant antimicrobial peptides thrombocidin-1 (tc-1) and thrombocidin-2 (tc-2) or variants thereof |
| 09/02/1999 | WO1999014234A3 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/02/1999 | WO1999002711A3 Fusion proteins with an immunoglobulin hinge region linker |
| 09/02/1999 | WO1998034632A9 Compounds and compositions for delivering active agents |
| 09/02/1999 | WO1998033917A9 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 09/02/1999 | WO1998030693A9 Tumor necrosis factor receptor 5 |
| 09/02/1999 | WO1998027113A8 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5 |
| 09/02/1999 | CA2792479A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | CA2640994A1 Enamel matrix protein composition for preventing or treating infection |
| 09/02/1999 | CA2322160A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | CA2321993A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity |
| 09/02/1999 | CA2321974A1 Tumor associated antigen 791tgp72 |
| 09/02/1999 | CA2321970A1 36 human secreted proteins |
| 09/02/1999 | CA2321962A1 G protein-coupled receptor antagonists |
| 09/02/1999 | CA2321959A1 Methods for diagnosing and treating autoimmune disease |
| 09/02/1999 | CA2321947A1 High affinity humanized anti-cea monoclonal antibodies |
| 09/02/1999 | CA2321946A1 Methods and compositions using tumor specific soluble interleukin-2 receptor alpha molecules |
| 09/02/1999 | CA2321932A1 High affinity humanized anti-tag-72 monoclonal antibodies |
| 09/02/1999 | CA2321928A1 Cyclic peptide antifungal agents |
| 09/02/1999 | CA2321883A1 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 09/02/1999 | CA2321870A1 Cell cycle related proteins |
| 09/02/1999 | CA2321869A1 Human proteinase molecules |
| 09/02/1999 | CA2321747A1 Human smn-like protein |
| 09/02/1999 | CA2321746A1 Human protein kinase c inhibitor |
| 09/02/1999 | CA2321717A1 Oral compositions at low dosage of cytotoxic proteins |
| 09/02/1999 | CA2321704A1 Remedies for corneal epithelium disturbance |
| 09/02/1999 | CA2321667A1 Human channel-related molecules |
| 09/02/1999 | CA2321223A1 Hla linked pre-eclampsia and miscarriage susceptibility gene |
| 09/02/1999 | CA2321178A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | CA2321142A1 Protease-activated receptor 4 and uses thereof |
| 09/02/1999 | CA2321114A1 Streptogramin derivatives, preparation method and compositions containing same |
| 09/02/1999 | CA2320764A1 Treatment of hiv infections |
| 09/02/1999 | CA2320289A1 Novel peptide copolymer compositions |
| 09/02/1999 | CA2319558A1 Injectable implants for tissue augmentation and restoration |
| 09/02/1999 | CA2319123A1 A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof |
| 09/02/1999 | CA2287226A1 Human c-maf compositions and methods of use thereof |
| 09/02/1999 | CA2284838A1 Somatotropin compositions mixed with vitamins |
| 09/01/1999 | EP0939131A2 Aminopeptidases |
| 09/01/1999 | EP0939128A2 New HCV isolates |
| 09/01/1999 | EP0939127A2 Humanized immunoglobulins and their production and use |
| 09/01/1999 | EP0939124A2 MGBP1 sequences |
| 09/01/1999 | EP0939123A2 Estrogen receptor-related polypetide SBPERR4 |
| 09/01/1999 | EP0939121A2 TNF-binding proteins |
| 09/01/1999 | EP0939085A1 A process for the purification of a motility-promoting protein from buffalo serum |
| 09/01/1999 | EP0939084A1 An estrogen binding proteinaceous substance, its possible role in estrogen action, and potential use. |
| 09/01/1999 | EP0939083A2 Ferro-succinylcasein complex, process for its preparation and pharmaceutical compositions containing it |
| 09/01/1999 | EP0939082A1 Protein polysaccharide 0041 |
| 09/01/1999 | EP0938904A1 Mammalian cell transduction for use in gene therapy |
| 09/01/1999 | EP0938902A1 Human growth hormone-containing aqueous pharamceutical composition |
| 09/01/1999 | EP0938901A1 Medicinal compositions for treating liver diseases |
| 09/01/1999 | EP0938900A1 Preventives/remedies for stomatitis |
| 09/01/1999 | EP0938881A1 Collagen-base auxiliary agent for ophthalmic surgery |
| 09/01/1999 | EP0938850A1 Food or pharmaceutical composition and preparations containing the same |